
==== Front
Cardiol J
Cardiol J
Cardiology Journal
1897-5593
1898-018X
Via Medica

37853826
10.5603/cj.93107
cardj-31-4-553
Clinical Cardiology: Original Article
Association between cognitive impairment and risk of atrial fibrillation: The Atherosclerosis Risk in Communities study
Li Yizhou 12*
Jia Yu 1*
Jiang Wenli 13
Li Dongze 4
Yu Jing 4
Liu Yi 4
Liao Xiaoyang 1
Zhao Zhiwei 5
1 General Practice Ward/International Medical Center Ward, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, China
2 State Key Laboratory of Oral Diseases and National Center for Stomatology and National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China
3 Institute of Biomedical Engineering, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, China
4 Department of Emergency Medicine, Disaster Medical Center, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, Sichuan, China
5 West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, Sichuan, China
Address for correspondence: Prof. Xiaoyang Liao, MD, Department of General Practice, General Practice Medical Center, West China Hospital, West China School of Medicine, Sichuan University, 37 Guoxue Road, Chengdu 610041, Sichuan, China, tel/fax: +86-028-85582944, e-mail: liaoxiaoyang@wchscu.cn; Prof. Zhiwei Zhao, MD, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Wuhou District People’s South Road of 17, Chengdu 610041, Sichuan, China, tel/fax: +86-028-85582944, +86-028-85582944, e-mail: zzw2002400@126.com
* These authors contributed equally to this work.

2024
29 8 2024
31 4 553563
08 12 2022
22 9 2023
Copyright © 2024 Via Medica
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
Background

Atrial fibrillation (AF) is reportedly a risk factor for cognitive impairment. Interestingly, recent studies have emphasized that impaired cognition is probably an initiating factor of cardiovascular disease. Thus, we aimed to explore the association between impaired cognition and the risk of AF, and clarify the potential mechanisms.

Methods

Participants of visit 2 (1991–1993) in the Atherosclerosis Risk in Communities study were included. Global cognition z-scores and factor scores were calculated using the word fluency, delayed word recall, and digit symbol substitution tests. AF incidents were diagnosed by electrocardiography and inpatient records. The association of cognitive decline with AF risk and left atrial volume index (LAVI) was explored using Cox proportional hazards and linear regression models, respectively.

Results

During the median follow-up of 18.2 ± 6.2 years, 2056/11,675 (17.6%) participants developed AF. Participants in the lowest quartile of global cognition z-scores and factor scores had a higher risk of AF (hazard ratio [HR]: 1.271, 95% confidence interval [CI]: 1.094–1.477, p = 0.002; HR: 1.305, 95% CI: 1.110–1.535, p = 0.001, respectively) than those in the highest quartile. Global cognition z-scores and factor scores were negatively correlated with the LAVI (B: −0.411, 95% CI: −0.749 to −0.074, p = 0.017; B: −0.425, 95% CI: −0.833 to −0.017, p = 0.041, respectively).

Conclusions

Cognitive decline is significantly associated with a higher risk of AF, with atrial remodeling being a potential mechanism. Our results extend previous findings of the brain-heart axis and indicate the effects of cognitive injury on cardiac function and structure.

Registration

URL: https://www.clinicaltrials.gov; unique identifier: NCT00005131

cognitive function
atrial fibrillation
atrial remodeling
stroke
Atherosclerosis Risk in Communities study
National Key Research and Development Program of China2020AAA0105000 2020AAA0105005 Sichuan Science and Technology Program2022YFS0279 2021YFQ0062 2022JDRC0148 Sichuan Provincial Health CommissionZH2022- 101 Sichuan University West China Nursing Discipline Development Special Fund ProjectHXHL20017 HXHL20046 HXHL21016
==== Body
pmcIntroduction

One of the most common supraventricular arrhythmias is atrial fibrillation (AF), and there are over 37 million prevalent cases of AF globally [1]. AF is more common in older individuals, ranging from 3.8% and 9% over the ages of 60 and 80 years, respectively [2]. AF is of particular concern because it increases risk of stroke almost fivefold [3], and it is estimated that ischemic strokes occur in 30% of patients with AF [4]. In addition, AF is also related to a higher risk of heart failure, coronary heart disease, and death [5, 6]. Although catheter ablation is a valuable therapy for AF [7], the arrhythmia-free survival rate is only 29% at 5 years [8]. Therefore, it is crucial to find novel risk factors that could aid in targeted prevention.

Cognitive decline refers to the deterioration of memory, attention, language, or executive function and is common in the older population [9, 10]. Multiple cohort studies have repeatedly confirmed that cardiovascular diseases such as AF [11, 12], heart failure [13], and coronary heart disease [14] are independent risk factors for cognitive impairment or dementia. Interestingly, according to the brain-heart axis, a brain-heart interaction exists, which implies that lesions in the brain may negatively impact the structure or function of the heart by catecholamine release, central autonomic dysregulation, inflammation, etc. [15]. For example, atrial growth and a decreased left ventricular ejection fraction can be detected after cerebral ischemic injury [16, 17]. Our previous study demonstrated that cognitive decline is related to myocardial strain and damage [18]. Atrial remodeling is crucial in the occurrence and development of AF [19]. Thus, we hypothesized that early cognitive decline reflecting brain injury might predict atrial remodeling and AF. Determining the association between these factors may provide a new theory and target for the clinical prevention and intervention of AF.

Furthermore, several previous studies have indicated that impaired cognition is related to a higher risk of stroke [20, 21]; however, the mechanism remains unclear. Considering that AF is a powerful and independent risk factor for stroke [3], we hypothesized that AF may be a mediator of cognitive decline and stroke. Thus, in the present study, we primarily aimed to investigate if cognitive function at baseline is related to the risk of AF and further explore the association between cognitive decline and atrial size. We also analyzed whether the impact of cognitive function on stroke is mediated by AF.

Methods

Study design and population

Atherosclerosis Risk in Communities (ARIC) is a prospective cohort study that investigated the risk factors of atherosclerosis and other cardiovascular diseases [22]. A total of 15,792 participants aged 45 through 65 years were enrolled in the study between 1987 and 1989, and they were sampled from 4 communities: the northwest suburbs of Minneapolis, MN; Washington County, MD; Forsyth County, NC; and Jackson, MS. The participants underwent a comprehensive examination of their social, medical, and demographic data. After the baseline examination (visit 1), 4 additional examinations (visit 2–5) were performed during 1990–1992, 1993–1995, 1996–1998, and 2011–2013, respectively. The institutional review boards of all the involved institutes authorized the research program, and all participants signed consent forms.

In this study, 14,348 participants were enrolled during visit 2 (1990–1992). Individuals without cognitive tests (n = 1608), those with prevalent AF (n = 28), those without covariates (n = 755), and those who failed to undergo AF follow-up (n = 282) were excluded. After exclusions, 11,675 participants remained to analyze the relationship between cognitive impairment and risk of AF (visit 5). For 2 subsequent studies, 4865 participants were included to analyze the association between cognitive function and the size of the left atrium (LA) (visit 5), after excluding 6810 participants without an LA volume index. Moreover, to analyze the mediating effect of AF on cognitive function and stroke, we excluded patients with stroke that occurred before AF (n = 804) and those with hemorrhagic stroke (n = 15); thus, 10,865 participants were included (Fig. 1).

Cognitive assessment

Participants were given neuropsychological tests using a standardized protocol by trained examiners in a quiet room. The tests included the delayed word recall test (DWRT), digit symbol substitution test (DSST), and word fluency test (WFT) [23]. Verbal learning and memory were examined in the DWRT; participants were asked to learn 10 words, use these words to make sentences, and repeat them after 5 minutes. Participants were given scores for the number of words they could recall. In the DSST, which aimed to test processing speed and executive function, symbols were translated into numbers by participants using a keyboard, and the score represented the number of symbols translated correctly. The WFT measures expressive language and executive functioning. Participants were required to write as many words as possible starting with A, F, and S within 90 s. Their scores were the number of correct words they generated. To facilitate comparison across cognitive tests, the global cognition z-score was calculated as the mean of the 3 individual z-scores, and the mean and standard deviation (SD) were used to standardize the scores. In the factor analysis, the scores were derived for 3 domains: language, executive function, and memory. The global cognition factor score was a scaled combination of the 3 cognitive domains [12].

Ascertainment of AF

The methods to ascertain AF have been described in detail [24]. In brief, there were 3 sources to obtain AF diagnoses: electrocardiograms between visit 2 and 5, hospital discharge records, and death certificates. AF was automatically coded by the electrocardiogram recordings and confirmed by a trained cardiologist. Through annual interviewing and surveillance of local hospitals, hospitalization data of the participants were obtained. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9) coded 427.31 or 427.32 represented the incidence of AF. AF was also defined if ICD-10 code I48 or ICD-9 code 427.3 were listed as one of the mortal causes in the death certificates. The date on which AF occurred was defined as the date of the first electrocardiogram diagnosis of AF, the first AF diagnosis in hospital discharge records, or death caused by AF, whichever occurred first.

Assessment of left atrial size

Two-dimensional echocardiography using apical 4- and 2-chamber views was performed to assess LA volume at the end of systole before mitral valve opening. More details regarding the design and protocols have been described previously [25]. Thereafter, the LA volume index was obtained by indexing the LA volume to body surface based on American Society of Echocardiography guidelines [26].

Ascertainment of stroke

Annual contact was performed to obtain hospitalizations and deaths of ARIC participants during the preceding year. Cardiovascular disease discharges provided by local hospitals were also examined. Possible stroke was identified if discharges had ICD-9 codes 430–438 until 1997 and ICD-9 codes 430–436 or ICD-10 codes G45.X, I60.X, I61.X, I62.X, I63.X, I65.X, I66.X, and I67.X after 1997. Patients with cerebrovascular findings revealed by computed tomography or magnetic resonance imaging scan or hospitalized in a neurological intensive care unit were eligible. All stroke events were confirmed carefully by a neurologist and adjudicated as ischemic or hemorrhagic stroke [27, 28].

Covariate assessment

Baseline medical, lifestyle, and demographic conditions were obtained at visit 2. Income was categorized as low, middle, and high, which represented < $16,000, $16,000–$35,000, and > $35,000, respectively. Level of educational attainment was separated as less than high school, high school, and college. Drinking and smoking habits were separated as never, former, and current. The calculation of body mass index was kg/m2. A random zero sphygmomanometer was used to measure blood pressure 3 times, and the recordings were averaged. Participants with non-fasting blood glucose ≥ 200 mg/dL, fasting blood glucose ≥ 126 mg/dL, or those who previously used hypoglycemic drugs were defined as having diabetes. Participants with systolic blood pressure ≥ 140 mmHg, diastolic blood pressure ≥ 90 mmHg, or those who previously used hypotensive drugs were defined as having hypertension. Chronic obstructive pulmonary disorder (COPD) was defined according to the results of obstructive vital capacity measurement model or doctor’s diagnosis. Glucose-6-phosphate dehydrogenase or modified hexokinase method were used for the measurement of fasting blood glucose. Total cholesterol and high-density lipoprotein cholesterol were measured by an enzymatic method and precipitation method, respectively.

Statistical analysis

Participants were classified into quartiles (Q1, Q2, Q3, and Q4) according to their global cognition z- and global cognition factor score. Nonparametric and parametric variables are presented as medians (25th and 75th percentiles) and mean ± SD, respectively; the Mann–Whitney U-test, Kruskal–Wallis H test, and analysis of variance were used to compare them. Categorical variables are presented as frequencies and percentages and compared by the chi-square test.

A Cox proportional hazards model was performed for analysis of the relationship between cognitive function and occurrence of AF; hazard ratios (HRs) and 95% confidence intervals (CIs) were obtained. For further determination of independent risk factors, the model was adjusted for demographic variables (sex, income, education, race, age), lifestyle (drinking, smoking), physical and lab variables (body mass index, total cholesterol, heart rate, high-density lipoprotein, triglycerides, systolic blood pressure), and chronic medical conditions (COPD, diabetes, hypertension). After adjusting for confounding factors, different subgroups were stratified by sex, race, age, diabetes, and hypertension, and the Cox proportional hazards model was used to analyze the association between cognitive function and AF in these subgroups.

A linear regression model was used to evaluate the association between cognitive function and LA size. The model covariates were the same as those used to investigate the association between cognitive function and AF.

The degree to which AF mediates the association between cognitive decline and stroke was analyzed by path analysis using structural equation modeling [29]. The proportion of the mediating effect was calculated as the estimated indirect effect size divided by the estimated total effect size. The results are shown by HR and mediated proportions.

A 2-tailed p value of < 0.05 was considered significant for all tests. All statistical analyses were performed using SPSS version 26.0 (IBM Corp, Armonk, NY, United States) and R software 3.5.0 (Vienna, Austria).

Results

Baseline characteristics

A total of 11,675 participants were included in our study. The average age of the participants was 57.1 ± 5.7 years; 6378 (54.6%) were male, and 9223 (79%) were Caucasian. During the 18.2 ± 6.2 years of follow-up, 2056 (17.6%) participants developed AF. Baseline characteristics (1990–1992) were described and compared based on the occurrence of AF (Table 1). Compared to participants without AF, participants with AF were more likely to be older, female, African American, and have lower education and income, while also having smoking habits, hypertension, diabetes, and COPD (p < 0.05). In addition, participants with AF had significantly lower global cognition z- and global cognition factor scores (p < 0.001). Baseline participant characteristics by quartiles of global cognition z-scores were also compared (Suppl. Table 1).

Cognitive function and AF

In the adjusted Cox proportional hazards model, participants in the lowest quartile (Q1) of global cognition z- and global cognition factor scores had a higher risk of AF (HR: 1.271, 95% CI: 1.094–1.477, p = 0.002; HR: 1.305, 95% CI: 1.110–1.535, p = 0.001, respectively) than those in Q4 (Table 2). Associations of lower DSST, language, memory, and executive functioning domain factor scores with a higher risk of AF were significant in unadjusted and adjusted Cox proportional hazards models (Suppl. Table 2).

Subgroup analysis

A significant association between cognitive scores and the risk of AF was observed in the subgroups stratified by sex, age, race, hypertension, and diabetes. Furthermore, the association between cognition decline and an increased risk of AF was stronger in participants with diabetes or hypertension than in those without it (Fig. 2).

Cognitive function and left atrial size

Participants with lower global cognition z- or factor scores had significantly higher LA volume indices. In the adjusted linear regression model, global cognition z- and factor scores were negatively correlated with the LA volume index (B: −0.411, 95% CI: −0.749 to −0.074, p = 0.017; B: −0.425, 95% CI: −0.833 to −0.017, p = 0.041, respectively; Table 3).

Mediation analysis

A significant mediating effect of AF on the relationship between cognitive function and stroke was observed (Table 4). In the structural equation modeling, the indirect effects of global cognition z-scores (Q1 vs. Q4) and factor scores (Q1 vs. Q4) on stroke mediated by AF were 23.4% (HR: 1.236) and 29.3% (HR: 1.472), respectively.

Discussion

In the prospective cohort of the ARIC study with a large number of participants over a long follow-up period, we found a significant association between cognitive impairment and AF. Participants with the lowest quartile of cognition score had a > 25% higher risk of AF even after adjusting for other risk factors such as smoking, drinking, hypertension, and diabetes. Moreover, we found that impairment of language and executive functioning domains were independent impact factors of AF. Declined cognition is associated with a larger LA volume, which may explain the potential relationship between impaired cognition and AF. Finally, we demonstrated that > 20% of the effects of cognitive impairment on stroke were mediated by AF.

Considering that age, race, comorbidities, and other covariates significantly impact cognition [30–33], we performed a subgroup analysis suggesting a consistent relationship between cognitive impairment and AF in the subgroups stratified by sex, age, race, hypertension, and diabetes. Notably, the association was stronger in participants with hypertension or diabetes than in those without (p for interaction < 0.05), which indicates that declined cognition in combination with hypertension or diabetes increases the risk of AF; thus, preventive measures should be considered for such a population to prevent the occurrence of AF.

The relationship between cognitive decline and AF incidents may be multipath. First, we considered atrial remodeling as the most crucial impact factor of AF. According to the brain-heart axis, most common causes of cognitive decline, such as Alzheimer’s disease, vascular dementia, psychological stress, and covert stroke [34, 35], may lead to cardiac remodeling through hyperactivation of the sympathetic nerve, catecholamine release, inflammation, etc. [15]. We analyzed the association between cognitive function and LA volume and found a significant negative correlation. Thus, atrial remodeling is probably a key mechanism for the association between cognitive decline and AF. Second, cognitive decline and AF share similar cardiovascular disease risk factors, such as aging, smoking, obesity, hypertension, and diabetes [36, 37]. Thus, cardiovascular disease risk factors may indirectly mediate the association between cognitive decline and AF.

Atrial fibrillation is recognized as a crucial risk factor for stroke, which brings a huge social and economic burden; thus, it has been receiving increasing attention. Several studies have demonstrated that populations with cognitive decline have a higher risk of stroke. The authors of these studies proposed some potential mechanisms, such as unrecognized cerebrovascular injury [38] or higher polygenic risk [39]. Notably, we used a structural equation to investigate whether AF mediates the association between cognitive function and stroke. Therefore, these results provide a strong clinical implication that the cognitive function-AF-stroke axis is an important intervention pathway, and early cognitive assessment and intervention may help to reduce the prevalence of AF and related complications.

Limitations of the study

Our study has some limitations. First, we did not distinguish between paroxysmal AF and persistent AF, in which cognitive decline may have different effects. Second, AF was identified primarily from hospitalization discharges and study electrocardiograms; therefore, asymptomatic AF and AF treated only in the outpatient setting may not have been included in our study. Third, several other validated assessment tools for cognitive function [9, 40] were unavailable for the ARIC study. Fourth, we adjusted our model using several risk factors; however, we could have missed some potential factors, such as psychological factors. Fifth, the participants we investigated were chiefly middle-aged or older people in the community; therefore, whether the results are consistent in young people remains unclear. Sixth, echocardiography was performed at visit 5 (2011–2013), and over 80% of AF occurred before the echocardiography examination. Therefore, the study lacks direct evidence that atrial remodeling mediates the relationship between cognitive function and AF.

Conclusions

Our study provides evidence that cognitive decline is associated with a high risk of AF. Declined cognition is associated with a larger left atrial volume, which may explain the potential relationship between impaired cognition and AF. Moreover, AF is a mediator of cognitive decline and stroke. Therefore, cognitive decline is not only the outcome of cardiovascular disease but also the original risk factor of atrial remodeling, AF, and stroke.

Supplementary Information

Figure 1 Study flow chart; AF — atrial fibrillation; ARIC — Atherosclerosis Risk in Communities; LA — left atrium

Figure 2 Adjusted hazard ratios (HR) (95% confidence intervals) for the association of baseline (1990–1992) cognition function with the occurrence of atrial fibrillation in different subgroups. Multivariate Cox regression analysis between cognition function and occurrence of atrial fibrillation adjusted by age (< 57, ≥ 57 years), sex, center-race, education (< high school, high school, or > high school), annual household income (< $16,000, $16,000 to $35,000, or > $35,000), smoking (never, former, current), drinking (never, former, current), body mass index, systolic blood pressure, heart rate, total cholesterol, triglycerides, high density lipoprotein, hypertension, diabetes, and chronic obstructive pulmonary disease

Table 1 Baseline (1990–1992) participant characteristics by the occurrence of atrial fibrillation (AF)

	Total (n = 11,675)	Non-AF (n = 9619)	AF (n = 2056)	P	
Demographic variables	
Age [years]	57.1 ± 5.71	56.6 ± 5.66	59.4 ± 5.4	< 0.001	
Male sex	6378 (54.6)	5422 (56.4)	956 (46.5)	< 0.001	
Caucasian	9223 (79.0)	7467 (77.6)	1756 (85.4)	< 0.001	
Education:	< 0.001	
 Less than high school	2367 (20.3)	1874 (19.5)	493 (24.0)		
 High school	3690 (31.6)	3030 (31.5)	660 (32.1)		
 College	5618 (48.1)	4715 (49.0)	903 (43.9)		
Income, US$:	0.003	
 < 16,000	2252 (19.3)	1845 (19.2)	407 (19.8)		
 16,000–35,000	3927 (33.6)	3179 (33.0)	748 (36.4)		
 > 35,000	5496 (47.1)	4595 (47.8)	901 (43.8)		
Smoking:	< 0.001	
 Never	4630 (39.7)	3917 (40.7)	713 (34.7)		
 Former	4450 (38.1)	3593 (37.4)	857 (41.7)		
 Current	2595 (22.2)	2109 (21.9)	486 (23.6)		
Drinking:	0.015	
 Never	2534 (21.7)	2125 (22.1)	409 (19.9)		
 Former	2348 (20.1)	1895 (19.7)	453 (22.0)		
 Current	6793 (58.2)	5599 (58.2)	1194 (58.1)		
Physiological and lab variables	
Body mass index [kg/m2]	27.9 ± 5.31	27.6 ± 5.18	29.0 ± 5.78	< 0.001	
SBP [mmHg]	118 (108, 131)	117 (108, 130)	123 (112, 136)	< 0.001	
DBP [mmHg]	71.0 (65.0, 78.0)	71.0 (65.0, 78.0)	72.0 (65.0, 78.0)	0.655	
Heart rate [/min]	65.0 (59.0, 72.0)	65.0 (59.0, 72.0)	64.0 (58.0, 71.0)	0.032	
Total cholesterol [mmol/L]	5.41 ± 1.00	5.42 ± 1.01	5.38 ± 0.97	0.079	
HDL [mmol/L]	1.28 ± 0.43	1.30 ± 0.43	1.21 ± 0.40	< 0.001	
LDL [mmol/L]	3.46 ± 0.95	3.46 ± 0.96	3.45 ± 0.90	0.745	
Triglycerides [mmol/L]	1.47 ± 0.74	1.45 ± 0.73	1.57 ± 0.78	< 0.001	
Creatinine [mg/dL]	1.15 ± 0.31	1.14 ± 0.31	1.17 ± 0.30	< 0.001	
Blood glucose [mmol/L]	5.72 (5.33, 6.22)	5.66 (5.33, 6.16)	5.83 (5.44, 6.49)	< 0.001	
Chronic medical conditions	
Hypertension	3323 (28.5)	2538 (26.4)	785 (38.2)	< 0.001	
Diabetes mellitus	1631 (14.0)	1238 (12.9)	393 (19.1)	< 0.001	
COPD	2652 (22.7)	2033 (21.1)	619 (30.1)	< 0.001	
Cognition score	
Global cognition z-score	0.10 (-0.58, 0.71)	0.12 (−0.56, 0.74)	-0.02 (-0.69, 0.56)	< 0.001	
DWRT score	7 (6, 8)	7 (6, 8)	7 (6, 7)	< 0.001	
DSST score	46 (37, 55)	47 (37, 55)	44 (36, 53)	< 0.001	
WFT score	33 (25, 42)	33 (25, 42)	32 (24, 40)	0.001	
Global cognition factor score	0.11 (−0.51, 0.65)	0.13 (−0.50, 0.66)	−0.03 (−0.60, 0.53)	< 0.001	
Language domain factor score	0.07 (−0.51, 0.38)	0.07 (−0.51, 0.38)	0.07 (−0.51, 0.38)	0.003	
Memory domain factor score	0.12 (−0.24, 0.47)	0.12 (−0.24, 0.47)	0.11 (−0.24, 0.12)	< 0.001	
Executive domain factor score	0.01 (−0.27, 0.36)	0.03 (−0.25, 0.37)	−0.02 (−0.32, 0.22)	< 0.001	
Values are expressed as number (%), mean ± standard deviation, and median (25th, 75th). Global cognition z-score was calculated by computing the mean from the z score versions of the DSST, WFT, and DWRT administered during the visit 2; SBP — systolic blood pressure; DBP — diastolic blood pressure; HDL — high-density lipoprotein; LDL — low-density lipoprotein; COPD — chronic obstructive pulmonary disease; DSST — digit symbol substitution test; WFT — word fluency test; DWRT — delayed word recall test

Table 2 Unadjusted and adjusted hazard ratios (HR) (95% confidence interval [CI]) for the association of baseline (1990–1992) cognition function with presence of atrial fibrillation

Variable	Quartile	Unadjusted	Adjusted	
		
HR (95% CI)	P	HR (95% CI)	P	
Global cognition z-score:			< 0.001		0.015	
	Q1	1.853 (1.634–2.102)	< 0.001	1.271 (1.094–1.477)	0.002	
	Q2	1.496 (1.317–1.699)	< 0.001	1.154 (1.010–1.319)	0.036	
	Q3	1.284 (1.127–1.463)	< 0.001	1.082 (0.947–1.235)	0.245	
	Q4	Reference	–	Reference	–	
Global cognition factor score:			< 0.001		0.014	
	Q1	1.859 (1.633–2.116)	< 0.001	1.305 (1.110–1.535)	0.001	
	Q2	1.675 (1.473–1.904)	< 0.001	1.185 (1.033–1.360)	0.015	
	Q3	1.423 (1.249–1.622)	< 0.001	1.148 (1.005–1.311)	0.043	
	Q4	Reference	–	Reference	–	
Univariate and multivariate Cox regression analysis between cognition function and presence of atrial fibrillation. Multivariate Cox regression was adjusted by age (< 57, ≥ 57), sex, center-race, education (< high school, high school, or > high school), annual household income (< $16,000, %16,000 to $35,000, or > $35,000), smoking (never, former, current), drinking (never, former, current), body mass index, systolic blood pressure, heart rate, total cholesterol, triglycerides, high-density lipoprotein, hypertension, diabetes, and chronic obstructive pulmonary disease

Table 3 Univariate and multivariate liner regression analysis between cognition function and left atrial volume index

	B (95% CI)	SE	β	t	P	
Unadjusted	
Global cognition z-score	−0.948 (−1.227 to −0.668)	0.142	−0.095	−6.653	< 0.001	
Global cognition factor score	−1.067 (−1.385 to −0.750)	0.162	−0.094	−6.593	< 0.001	
Adjusted	
Global cognition z-score	−0.411 (−0.749 to −0.074)	0.172	−0.041	−2.391	0.017	
Global cognition factor score	−0.425 (−0.833 to −0.017)	0.208	−0.037	−2.044	0.041	
Multivariate liner regression was adjusted by age (< 57, ≥ 57), sex, center-race, education (< high school, high school, or > high school), annual household income (< $16,000, $16,000 to $35,000, or > $35,000), total cholesterol, triglycerides, high-density lipoprotein, hypertension, diabetes, and chronic obstructive pulmonary disease; CI — confidence interval; SE — standard error

Table 4 Estimated direct and indirect effect sizes of impaired cognitive function on stroke mediated by atrial fibrillation

Cognitive function	Case/total [%]	HR (95% CI)	Mediated b	
	
Total effect	Direct effect	Indirect effect	
Global cognition z-score:	
Q1	70/2714 (2.6%)	1.956 (1.423–2.689)	1.603 (1.312–2.037)	1.236 (1.082–1.542)	23.4%	
Q2	63/2714 (2.3%)	1.768 (1.258–2.398)	1.529 (1.164–1.895)	1.165 (1.010–1.463)	18.7%	
Q3	43/2714 (1.6%)	1.256 (0.896–1.787)	1.205 (0.873–1.719)	1.021 (0.738–1.359)	8.2%	
Q4	27/2714 (1.0%)	Reference	Reference	Reference	–	
Global cognition factor score:	
Q1	75/2715 (2.8%)	2.501 (1.976–3.269)	1.920 (1.511–2.590)	1.472 (1.132–1.825)	29.3%	
Q2	51/2725 (1.9%)	1.723 (1.251–2.306)	1.521 (1.172–2.001)	1.123 (0.998–1.271)	16.1%	
Q3	53/2708 (2.0%)	1.729 (1.259–2.287)	1.538 (1.159–1.928)	1.163 (1.009–1.442)	20.5%	
Q4	24/2708 (0.9%)	Reference	Reference	Reference	–	
Hazard ratio was calculated by Cox proportional hazards model. A total of 1000 iterations were performed for bootstrapping to estimate 95% bias-corrected confidence interval. The percentage mediated was calculated by log (estimated indirect effect)/log (estimated total effect). Bold value indicates p < 0.05; CI — confidence interval; HR— hazard ratio

Funding: This work was funded the National Key Research and Development Program of China (No. 2020AAA0105000, 2020AAA0105005), Sichuan Science and Technology Program (No. 2022YFS0279, 2021YFQ0062, 2022JDRC0148), Sichuan Provincial Health Commission (ZH2022- 101), and Sichuan University West China Nursing Discipline Development Special Fund Project (HXHL20017, HXHL20046, and HXHL21016).

Conflict of interest: None declared.
==== Refs
References

1 Dai H Zhang Q Much AA Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990–2017: results from the Global Burden of Disease Study 2017 Eur Heart J Qual Care Clin Outcomes 2021 7 6 574 582 10.1093/ehjqcco/qcaa061 32735316
2 Go AS Hylek EM Phillips KA Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the An Ticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study JAMA 2001 285 18 2370 2375 10.1001/jama.285.18.2370 11343485
3 Wolf PA Abbott RD Kannel WB Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 1991 22 8 983 988 10.1161/01.str.22.8.983 1866765
4 Boyle PM Del Álamo JC Akoum N Fibrosis, atrial fibrillation and stroke: clinical updates and emerging mechanistic models Heart 2021 107 2 99 105 10.1136/heartjnl-2020-317455 33097562
5 Magnani JW Norby FL Agarwal SK Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and Mortality: The Atherosclerosis Risk in Communities (ARIC) Study JAMA Cardiol 2016 1 4 433 441 10.1001/jamacardio.2016.1025 27438320
6 Wang TJ Larson MG Levy D Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study Circulation 2003 107 23 2920 2925 10.1161/01.CIR.0000072767.89944.6E 12771006
7 Haegeli LM Calkins H Catheter ablation of atrial fibrillation: an update Eur Heart J 2014 35 36 2454 2459 10.1093/eurheartj/ehu291 25053659
8 Weerasooriya R Khairy P Litalien J Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow- up? J Am Coll Cardiol 2011 57 2 160 166 10.1016/j.jacc.2010.05.061 21211687
9 Harvey P Domains of cognition and their assessment Dialogues Cin Neurosci 2019 21 3 227 237 10.31887/dcns.2019.21.3/pharvey
10 Eshkoor SA Hamid TA Mun CY Mild cognitive impairment and its management in older people Clin Interv Aging 2015 10 687 693 10.2147/CIA.S73922 25914527
11 Singh-Manoux A Fayosse A Sabia S Atrial fibrillation as a risk factor for cognitive decline and dementia Eur Heart J 2017 38 34 2612 2618 10.1093/eurheartj/ehx208 28460139
12 Chen LY Norby FL Gottesman RF Association of Atrial Fibrillation With Cognitive Decline and Dementia Over 20 Years: The ARIC-NCS (Atherosclerosis Risk in Communities Neurocognitive Study) J Am Heart Assoc 2018 7 6 10.1161/JAHA.117.007301 29514809
13 Bressler J Knopman DS Sharrett AR Incident Heart Failure and Cognitive Decline: The Atherosclerosis Risk in Communities Study J Card Fail 2017 23 1 47 55 10.1016/j.cardfail.2016.11.002 27864030
14 Singh-Manoux A Sabia S Lajnef M History of coronary heart disease and cognitive performance in midlife: the Whitehall II study Eur Heart J 2008 29 17 2100 2107 10.1093/eurheartj/ehn298 18648106
15 Sposato LA Hilz MJ Aspberg S Post-Stroke cardiovascular complications and neurogenic cardiac injury: JACC state-of-the-art review J Am Coll Cardiol 2020 76 23 2768 2785 10.1016/j.jacc.2020.10.009 33272372
16 Lee M Oh JuH Lee KB Clinical and echocardiographic characteristics of acute cardiac dysfunction associated with acute brain hemorrhage — difference from takotsubo cardiomyopathy Circ J 2016 80 9 2026 2032 10.1253/circj.CJ-16-0395 27385160
17 Adeoye AM Ogah OS Ovbiagele B Prevalence and prognostic features of ECG abnormalities in acute stroke: findings from the SIREN study among africans Glob Heart 2017 12 2 99 105 10.1016/j.gheart.2017.01.002 28302557
18 Li D Jia Yu Yu J Cognition impairment and risk of subclinical cardiovascular disease in older adults: The atherosclerosis risk in communities study Front Aging Neurosci 2022 14 889543 10.3389/fnagi.2022.889543 35966771
19 Nattel S Burstein B Dobrev D Atrial remodeling and atrial fibrillation: mechanisms and implications Circ Arrhythm Electrophysiol 2008 1 1 62 73 10.1161/CIRCEP.107.754564 19808395
20 Zhu L Fratiglioni L Guo Z Incidence of stroke in relation to cognitive function and dementia in the Kungsholmen Project Neurology 2000 54 11 2103 2107 10.1212/wnl.54.11.2103 10851370
21 Rajan KB Aggarwal NT Wilson RS Association of cognitive functioning, incident stroke, and mortality in older adults Stroke 2014 45 9 2563 2567 10.1161/STROKEAHA.114.005143 25104848
22 The ARIC Investigators The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives Am J Epidemiol 1989 129 4 687 702 10.1093/oxfordjournals.aje.a115184 2646917
23 Cerhan JR Folsom AR Mortimer JA Correlates of cognitive function in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators Gerontology 1998 44 2 95 105 10.1159/000021991 9523221
24 Magnani JW Norby FL Agarwal SK Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study Am Heart J 2009 158 1 111 117 10.1016/j.ahj.2009.05.010 19540400
25 Shah AM Cheng S Skali H Rationale and design of a multicenter echocardiographic study to assess the relationship between cardiac structure and function and heart failure risk in a biracial cohort of community-dwelling elderly persons: the Atherosclerosis Risk in Communities study Circ Cardiovasc Imaging 2014 7 1 173 181 10.1161/CIRCIMAGING.113.000736 24214885
26 Lang RM Badano LP Mor-Avi V Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging J Am Soc Echocardiogr 2015 28 1 1 39 e14 10.1016/j.echo.2014.10.003 25559473
27 Rosamond WD Folsom AR Chambless LE Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort Stroke 1999 30 4 736 743 10.1161/01.str.30.4.736 10187871
28 Koton S Schneider ALC Windham BG Microvascular brain disease progression and risk of stroke: the ARIC study Stroke 2020 51 11 3264 3270 10.1161/STROKEAHA.120.030063 32998653
29 Stein C Morris N Hall N Structural equation modeling Methods Mol Biol 2017 1666 557 580 10.1007/978-1-4939-7274-6_28 28980265
30 Hu X Gu S Zhen X Trends in cognitive function among chinese elderly from 1998 to 2018: an age-period-cohort analysis Front Public Health 2021 9 753671 10.3389/fpubh.2021.753671 34900900
31 Moheet A Mangia S Seaquist ER Impact of diabetes on cognitive function and brain structure Ann N Y Acad Sci 2015 1353 60 71 10.1111/nyas.12807 26132277
32 Iadecola C Gottesman RF Neurovascular and cognitive dysfunction in hypertension Circ Res 2019 124 7 1025 1044 10.1161/CIRCRESAHA.118.313260 30920929
33 Avila JF Vonk JMJ Verney SP Sex/gender differences in cognitive trajectories vary as a function of race/ethnicity Alzheimers Dement 2019 15 12 1516 1523 10.1016/j.jalz.2019.04.006 31606366
34 Fillit H Nash DT Rundek T Cardiovascular risk factors and dementia Am J Geriatr Pharmacother 2008 6 2 100 118 10.1016/j.amjopharm.2008.06.004 18675769
35 Alonso A Jacobs DR Menotti A Cardiovascular risk factors and dementia mortality: 40 years of follow-up in the Seven Countries Study J Neurol Sci 2009 280 1–2 79 83 10.1016/j.jns.2009.02.004 19251275
36 Jia L Du Y Chu L Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study Lancet Public Health 2020 5 12 e661 e671 10.1016/S2468-2667(20)30185-7 33271079
37 Kornej J Börschel CS Benjamin EJ Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights Circ Res 2020 127 1 4 20 10.1161/CIRCRE-SAHA.120.316340 32716709
38 Wiberg B Lind L Kilander L Cognitive function and risk of stroke in elderly men Neurology 2010 74 5 379 385 10.1212/WNL.0b013e3181ccc516 20124202
39 Harris SE Malik R Marioni R Polygenic risk of ischemic stroke is associated with cognitive ability Neurology 2016 86 7 611 618 10.1212/WNL.0000000000002306 26695942
40 Woodford HJ George J Cognitive assessment in the elderly: a review of clinical methods QJM 2007 100 8 469 484 10.1093/qjmed/hcm051 17566006
